Adjuvant effect of the novel TLR1/TLR2 agonist Diprovocim synergizes with anti–PD-L1 to eliminate melanoma in mice

Ying Wang, Lijing Su, Matthew D. Morin, Brian T. Jones, Yuto Mifune, Hexin Shi, Kuan-wen Wang, Xiaoming Zhan, Aijie Liu, Jianhui Wang, Xiaohong Li, Miao Tang, Sara Ludwig, Sara Hildebrand, Kejin Zhou, Daniel J. Siegwart, Eva Marie Y. Moresco, Hong Zhang, Dale L. Boger, and Bruce Beutler
PNAS September 11, 2018 115 (37) E8698-E8706; published ahead of print August 27, 2018 https://doi.org/10.1073/pnas.1809232115

  1. Edited by Dennis A. Carson, University of California, San Diego, La Jolla, CA, and approved July 2, 2018 (received for review June 28, 2018)

Online Impact

 

Article Information

vol. 115 no. 37 E8698-E8706
DOI: 
https://doi.org/10.1073/pnas.1809232115
PubMed: 
30150374
Published By: 
National Academy of Sciences
Print ISSN: 
0027-8424
Online ISSN: 
1091-6490
History: 
  • Published in issue September 11, 2018.
  • Published first August 27, 2018.
Copyright & Usage: 
© 2018 Published under the PNAS license.

Author Information

  1. Ying Wanga,
  2. Lijing Sua,
  3. Matthew D. Morinb,
  4. Brian T. Jonesb,
  5. Yuto Mifuneb,
  6. Hexin Shia,
  7. Kuan-wen Wanga,
  8. Xiaoming Zhana,
  9. Aijie Liua,
  10. Jianhui Wanga,
  11. Xiaohong Lia,
  12. Miao Tanga,
  13. Sara Ludwiga,
  14. Sara Hildebranda,
  15. Kejin Zhouc,d,
  16. Daniel J. Siegwartc,d,
  17. Eva Marie Y. Morescoa,
  18. Hong Zhanga,
  19. Dale L. Bogerb, and
  20. Bruce Beutlera,1
  1. aCenter for the Genetics of Host Defense, University of Texas Southwestern Medical Center, Dallas, TX 75390;
  2. bDepartment of Chemistry, The Scripps Research Institute, La Jolla, CA 92037;
  3. cSimmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390;
  4. dDepartment of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX 75390

  1. Edited by Dennis A. Carson, University of California, San Diego, La Jolla, CA, and approved July 2, 2018 (received for review June 28, 2018)

Footnotes

  • ↵1To whom correspondence should be addressed. Email: bruce.beutler{at}utsouthwestern.edu.

  • Author contributions: Y.W. and B.B. designed research; Y.W., L.S., H.S., K.-w.W., X.Z., A.L., J.W., X.L., M.T., S.L., S.H., K.Z., D.J.S., and H.Z. performed research; M.D.M., B.T.J., Y.M., and D.L.B. contributed new reagents/analytic tools; Y.W. and B.B. analyzed data; and Y.W., E.M.Y.M., and B.B. wrote the paper.

  • Conflict of interest statement: B.B. and D.L.B. have financial interests in Tollbridge Therapeutics, LLC, which has licensed the patent for Diprovocim.

  • This article is a PNAS Direct Submission.

  • This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1809232115/-/DCSupplemental.

Cited By...

Article usage

Article usage: August 2018 to March 2019

AbstractFullPdf
Aug 2018921174131
Sep 20182613722441133
Oct 20182902502268
Nov 20181315227120
Dec 201883115575
Total 20183210633021727
Jan 201989818198
Feb 20194919767
Mar 201927821183
Total 20191667489248
Total3377337911975
Back to top
Article Alerts
Email Article
Citation Tools
Request Permissions
Adjuvant effect of the novel TLR1/TLR2 agonist Diprovocim synergizes with anti–PD-L1 to eliminate melanoma in mice
Ying Wang, Lijing Su, Matthew D. Morin, Brian T. Jones, Yuto Mifune, Hexin Shi, Kuan-wen Wang, Xiaoming Zhan, Aijie Liu, Jianhui Wang, Xiaohong Li, Miao Tang, Sara Ludwig, Sara Hildebrand, Kejin Zhou, Daniel J. Siegwart, Eva Marie Y. Moresco, Hong Zhang, Dale L. Boger, Bruce Beutler
Proceedings of the National Academy of Sciences Sep 2018, 115 (37) E8698-E8706; DOI: 10.1073/pnas.1809232115
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Proceedings of the National Academy of Sciences: 116 (12)
Current Issue

Submit

Jump to section

You May Also be Interested in

PNAS QnAs with NAS foreign associate and physicist Anne L’Huillier
Featured QnA
PNAS QnAs with NAS foreign associate and physicist Anne L’Huillier.
Image courtesy of Erika Weiland (photographer).
Brain. Image courtesy of Pixabay/geralt.
Sex differences in metabolic brain aging
Brain metabolism scans in individuals aged 20–82 years revealed that compared with male brains, female brains appeared three to four years younger on average, suggesting potential links between sex and human brain aging.
Image courtesy of Pixabay/geralt.